We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Continues Its Singulair Side-Effect Study
FDA Continues Its Singulair Side-Effect Study
January 16, 2009
More than 10 months after the FDA began studying whether Merck’s allergy and asthma drug Singulair had mood and behavioral side effects, the agency reports that no conclusion has been reached.